Skip to content
healthcare.dev
Get a free key

OPZELURA

NDC 50881-007, ruxolitinib, cream, from Incyte Corporation.

Product NDC
50881-007
Status
Listed
Labeler
Incyte Corporation
Dosage form
CREAM
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA215309
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50881-007 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RUXOLITINIB PHOSPHATE15 mg/g

Pharmacologic classes

Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]; Kinase Inhibitor [EPC]

Package NDCNDC-11Package
50881-007-04508810007041 TUBE in 1 CARTON (50881-007-04) / 5 g in 1 TUBE
50881-007-05508810007051 TUBE in 1 CARTON (50881-007-05) / 60 g in 1 TUBE
50881-007-07508810007071 TUBE in 1 CARTON (50881-007-07) / 100 g in 1 TUBE
50881-007-14508810007141 TUBE in 1 CARTON (50881-007-14) / 3 g in 1 TUBE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/24da5509-6631-4795-9d42-273faecd08e7

  • NADAC price for package 50881000705

    GET /v1/drugs/nadac/50881000705

Use it

Look up 50881-007 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50881-007 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50881-007. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.